A Randomized Phase II Trial for Patients with p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer (NRG-HN002)
Sponsor: NRG Oncology
Protocol number: HN-002
Projected enrollment dates: January 2015 to January 2018
Official study title: A Randomized Phase II Trial for Patients with p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer (NRG-HN002)
ClinicalTrials.gov page:
http://www.clinicaltrials.gov/show/TBD